marketcap
Health Sciences Acquisitions Corporation 2 HSAQ
$ 10.45
-2.52%
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Health Sciences Acquisitions Corporation 2 Balance Sheet 2011-2024 | HSAQ
Annual Balance Sheet Health Sciences Acquisitions Corporation 2
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-28.9 M | -17.4 M | - | -2.03 M | - | - | - | - | - | - | - | - | - |
Long Term Debt |
1.04 M | 1.68 M | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
649 K | 697 K | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 5.6 M | - | - | - | - | - | - | - | - | - |
Total Current Liabilities |
11.2 M | 18.6 M | 166 K | 119 K | - | - | - | - | - | - | - | - | - |
Total Liabilities |
27.2 M | 43 M | 5.77 M | 5.72 M | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
2.51 M | 6.44 M | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-249 M | -200 M | -3.94 M | -174 K | - | - | - | - | - | - | - | - | - |
Total Assets |
95.2 M | 95.6 M | 162 M | 162 M | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
30.6 M | 19.8 M | 1.75 M | 2.03 M | - | - | - | - | - | - | - | - | - |
Book Value |
68 M | 52.5 M | 156 M | 156 M | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
68 M | 52.5 M | -3.94 M | -3.56 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Health Sciences Acquisitions Corporation 2
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
1.44 M | 1.1 M | 1.16 M | 1.04 M | 10 M | 10 M | 1.5 M | 1.68 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
29.1 M | 28.3 M | 25.4 M | 27.2 M | 36.7 M | 36.4 M | 36.5 M | 43 M | 7.04 M | 6.7 M | 5.91 M | 5.77 M | 5.74 M | 5.79 M | 5.77 M | 5.72 M | 5.72 M | 5.72 M | 5.72 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
4.07 M | 3.66 M | 3.07 M | 2.51 M | 3.68 M | 4.29 M | 5.32 M | 6.44 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-294 M | -278 M | -262 M | -249 M | -236 M | -223 M | -211 M | -200 M | -6.07 M | -5.25 M | -4.38 M | -3.94 M | -3.85 M | -374 K | -282 K | -3.56 M | -3.56 M | -174 K | -174 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
75.3 M | 72.4 M | 82.6 M | 95.2 M | 116 M | 126 M | 136 M | 95.6 M | 68.6 M | 162 M | 162 M | 162 M | 162 M | 162 M | 162 M | 162 M | 162 M | 162 M | 162 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
25.6 M | 23.7 M | 23.3 M | 30.6 M | 19.1 M | 16.4 M | 18.7 M | 19.8 M | 97 M | 107 M | 29.3 M | 1.75 M | 1.78 M | 1.91 M | 1.95 M | 2.03 M | 2.03 M | 2.03 M | 2.03 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
46.2 M | 44.1 M | 57.2 M | 68 M | 79.7 M | 89.4 M | 99.8 M | 52.5 M | 61.6 M | 155 M | 156 M | 156 M | 156 M | 156 M | 156 M | 156 M | 156 M | 156 M | 156 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
46.2 M | 44.1 M | 57.2 M | 68 M | 79.7 M | 89.4 M | 99.8 M | 52.5 M | 61.4 M | 69.5 M | 78 K | -3.94 M | -3.85 M | -3.76 M | -3.67 M | -3.56 M | -3.56 M | 5 M | 5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency